Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study have?
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study published?
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study has 2021 year in the ScholarIQ index.
What is the open-access status of Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study?
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study has gold oa status in the ScholarIQ index.
What is the DOI of Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study?
The DOI for Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study is on the source record.
What is the PMID of Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study?
The PMID for Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study is on the source record.
What is the OpenAlex record for Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study?
The OpenAlex for Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study is on the source record.